Hélène Lefebvre is the General Manager of Eclypia, a start-up developping a wearable non-invasive glucose sensor leveraging on the Quantum Cascade Lasers technology. In this role, she leads Eclypia's development strategy, manages the company's overall operations, overseeing several business elements.
She graduated from ESPCI ParisTech in 2010. She then received a PhD in biotechnologies from Université Technologique de Compiègne in 2013. Before instigating Eclypia, she worked as a project manager and product owner at Diabeloop, getting acquainted with regulatory and standards environment along with the complexity tied up with medical device development. Hélène also worked at Dow Chemical (Netherland) coordinating multidisciplinary projects and leading the Young Researcher network. Passionate about innovation, she is fond of turning projects into products, indentifying opportunities, defining and sharing a product strategy to meet user expectations and improve patients experience.
Guided by excellence, Eclypia tackles the challenges of developping wearable non-invasive biomolecule sensors. In a multi-disciplinary approach, a dedicated team gathers technological, physiological and algorithmic specialists to develop a unique photonic platform.
Eclypia has demonstrated the ability to manufacture high performing and low cost QCLs, through close collaboration with the CEA, and proved it possible to embed them in a wearable device. This opens a wide range of possibilities for middle infrared spectroscopy. The first developed sensor combines QCLs and photoacoustic detection, as well as proprietary machine learning algorithms, to estimate glycemia.